000 03116cam a2200337 a 4500
003 EG-GiCUC
005 20250223032405.0
008 190923s2019 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.10.M.Sc.2019.As.T
100 0 _aAsmaa Ibrahim Muhammed Ahmed Tahoun
245 1 0 _aTranexamic acid plus microneedling versus Vitamin C plus microneedling in Melasma patients :
_bcomparative split face single blinded study /
_cAsmaa Ibrahim Muhammed Ahmed Tahoun ; Supervised Wedad Zoheir Mostafa , Marwa Ahmed Amer
246 1 5 _aدراسة تأثير حمض الترانيكزمك بالاضافه الي الوخز بالابر الدقيقه (المجهريه) مقارنة بفيتامين سي بالاضافه الي الوخز بالابر الدقيقه (المجهريه) في مرضي الكلف :
_bدراسه تجزئه الوجه بالتعميه المفردة
260 _aCairo :
_bAsmaa Ibrahim Muhammed Ahmed Tahoun ,
_c2019
300 _a131 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology
520 _aBackground: Melasma is a complex common skin disorder mainly affecting females and characterized by irregular light to dark brown or grayish macules and/or patches mostly with underlying genetic, hormonal and environmental factors having no definitive treatment. Tranexamic acid (TXA) has lately gained popularity as an adjuvant therapy in some pigmentary disorders. Vitamin C (vit.C), an essential dietary nutrient, plays a role in the maintenance of proper skin functions through its action on wound healing, photoprotection, skin hydration, anti aging, as well as depigmentation. Aim of work: The present study aims at evaluating and comparing the therapeutic effects of topical TXA and Vit.C with microneedling (MN) in the treatment of melasma. Patients and methods: In a right-left comparative study, thirty female melasma patients were evaluated and underwent Wood{u2019}s light examination, dermoscopic evaluation, MASI scoring (mMASI, MASIMR and MASIML) by investigator and two blinded evaluators, and visual analogue score (VAS) by physician, by patient and blinded evaluators, as well as DLQI, before, during and after the study period (at 0,4,12 and 16 wks). Following a preliminary preparatory period of four weeks where Kligman{u2019}s formula was applied on both sides, the right side of the face was treated with TXA (500mg/5ml) plus microneedling and the left with Vit.C 20% followed by microneedling for five successive biweekly treatments. A final evaluation was performed four weeks after last treatment
530 _aIssued also as CD
653 4 _aTranexamic acid
653 4 _aVitamin C
653 4 _aWood{u2019}s light
700 0 _aMarwa Ahmed Amer ,
_eSupervisor
700 0 _aWedad Zoheir Mostafa ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAsmaa
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c74089
_d74089